Adverse drug events are frequently identified in the
|
|
|
- Benedict Owen
- 10 years ago
- Views:
Transcription
1 ETHICS, PUBLIC POLICY, AND MEDICAL ECONOMICS Computerized Physician Order Entry with Clinical Decision Support in Long-Term Care Facilities: Costs and Benefits to Stakeholders Sujha Subramanian, PhD, Sonja Hoover, MPP, Boyd Gilman, PhD, Terry S. Field, DSc, w Ryan Mutter, PhD, z and Jerry H. Gurwitz, MD w Nursing homes are the setting of care for growing numbers of our nation s older people, and adverse drug events are an increasingly recognized safety and quality concern in this population. Health information technology, including computerized physician/provider order entry (CPOE) with clinical decision support (CDS), has been proposed as an important systems-based approach for reducing medication errors and preventable drug-related injuries. This article describes the costs and benefits of CPOE with CDS for the various stakeholders involved in long-term care (LTC), including nurses, physicians, the pharmacy, the laboratory, the payer (e.g., the insurer), nursing home residents, and the LTC facility. Critical barriers to adoption of these systems are discussed, primarily from an economic perspective. The analysis suggests that multiple stakeholders will incur the costs related to implementation of CPOE with CDS in the LTC setting, but the costs incurred by each may not be aligned with the benefits, which may present a major barrier to broad adoption. Physicians and LTC facilities are likely to bear a large burden of the costs, whereas residents and payers will enjoy a large portion of the benefits. Consideration of these costs and benefits suggests that financial incentives to physicians and facilities may be necessary to encourage and accelerate widespread use of these systems in the LTC setting. J Am Geriatr Soc 55: , Key words: long-term care; economics; computer decision support From the RTI International, Waltham, Massachusetts; w Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic, Foundation, and Fallon Community Health Plan, Worcester, Massachusetts; and z Agency for Healthcare Research and Quality, Rockville, Maryland. Address correspondence to Jerry H. Gurwitz, MD, Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, 630 Plantation Street, Worcester, MA [email protected] DOI: /j x Adverse drug events are frequently identified in the nursing home setting; in a recent study of two large long-term care (LTC) facilities, the rate of adverse drug events was nearly 10 per 100 resident-months. 1 The same study indicated that a substantial proportion of the adverse drug events in these LTC facilities may have been preventable and that a majority of errors that were associated with adverse drug events occurred during the ordering and monitoring stages of pharmacotherapeutic management. If these findings are applied to the residents of all U.S. nursing homes, then approximately 1.9 million adverse drug eventsfmore than 40% of which are preventablefmay occur each year. Of all adverse drug events, 86,000 may be fatal or life-threatening. Health information technology, specifically through the implementation of computerized physician/provider order entry (CPOE) with clinical decision support (CDS), is increasingly encouraged as a solution to the challenge of medical error reduction and need for improvement in quality of care. The costs, benefits, and difficulties of implementation of CPOE with CDS in the hospital and ambulatory care settings have been discussed in several publications, 2,3 but only limited information is available on the use of these systems in LTC facilities. 4 Potential advantages of CPOE include elimination of handwriting identification problems, reductions in error associated with similar drug names, faster delivery of orders to the pharmacy, and integration with CDS systems that can provide prompts, for instance, regarding serious drug interactions. 5,6 This article provides a framework for considering the costs and benefits of CPOE with CDS in the LTC setting, together with a systematic assessment of the stakeholders involved, to identify barriers to adoption. The perspective taken in this overview is primarily economic, rather than clinical. It begins with a detailed description of the key stakeholders and their relationships. Potential costs and benefits are described, with a summary of factors that could affect their magnitude. It concludes with an assessment of potential barriers and the possible misalignment of benefits versus costs, which could result in disincentives to the adoption of these systems. JAGS 55: , 2007 r 2007, Copyright the Authors Journal compilation r 2007, The American Geriatrics Society /07/$15.00
2 1452 SUBRAMANIAN ET AL. SEPTEMBER 2007 VOL. 55, NO. 9 JAGS Long-Term Care Facility Residents Nurses Payers Medicare Medicaid Private Insurers Residents Physicians Pharmacy Lab laboratories would flow through the LTC facility, whereas under fee-for-service arrangements, the insurer will make direct payments to all providers. Payers, including Medicaid, Medicare, and private insurers, will have a direct relationship with the LTC facility, but the extent to which these payers have relationships with other stakeholders such as the laboratory and pharmacy will depend on the type of reimbursement provided, whether fee-for-service or capitation. Currently, Medicaid is the primary public payer for LTC services and the largest source of financing, accounting for approximately half of all LTC payments. 7 Medicaid payment for LTC varies from state to state, and therefore, there is substantial variation in how facilities are reimbursed and what services are capitated Individual relationships between physicians and residents Contractual relationships Figure 1. Stakeholder relationships under fee-for-service payment arrangements. Lab 5 Laboratory. STAKEHOLDERS IN THE LTC SETTING Figure 1 summarizes the relationships between selected stakeholders (nurses, physicians, the pharmacy, and the laboratory) involved in delivering care in the LTC setting. In most cases, only the nurses are employees of the facility. Physicians are generally not employees and bill an insurer for services provided. Pharmacies and laboratories usually provide services through agreements with the LTC facility and bill the insurer for these services. Under capitation, a single monthly or annual rate will be negotiated with the LTC facility, which is then responsible for providing the medical services required by residents under the contract. Therefore, under capitation, payments to pharmacies and Identifying the Potential Costs and Benefits The potential types of costs and benefits of implementing CPOE with CDS in the LTC setting are summarized in Table 1. The LTC facility will experience acquisition costs (an initial increase in costs that do not continue over time related to purchasing and implementing these systems), as well as annual costs (costs that occur over time). The facility will also incur training costs, which include the cost of compensating staff for time spent in training and lost productivity in resident care. Laboratories and pharmacies will also incur their own acquisition costs if they must create electronic data systems that are compatible with the nursing home s CPOE system, but because nursing homes are often part of larger organizations that contract with a limited number of large pharmacies and laboratory vendors that already have sophisticated information systems, the primary challenge in most cases will be to ensure that the existing laboratory Table 1. Costs and Benefits of Computerized Physician/Provider Order Entry (CPOE) with Clinical Decision Support (CDS) in the Long-Term Care Setting Costs or Benefits Item or Area Acquisition costs Annual costs Benefits Initial Purchase or Licensing of Systems Hardware and other infrastructure requirements Hiring additional staff (e.g., information technology related) Implementation of systems Integration of CPOE with CDS systems with vendors electronic networks Initial training of staff Lost productivity while becoming familiar with the system Maintenance of systems/annual license fees Upgrade and monitor systems Update of clinical and pharmaceutical information on CDS On-going staff training Increased laboratory costs due to more tests Increase in physician time Efficiency gains in nursing homes Efficiency gains in laboratories and pharmacies Decrease in billing errors and improved cash flow Reduction in costs related to storage of paper records Reduction in prescription drug costs Improved ability to produce patient education materials and medication lists Improved ability to access guidelines and standards for good prescribing Reduction in adverse drug events Reduction in medical costs associated with adverse drug events Improvements in patient health-related quality of life Improved ability to conduct research to further improve patient care
3 JAGS SEPTEMBER 2007 VOL. 55, NO. 9 HEALTH INFORMATION TECHNOLOGY IN LONG-TERM CARE 1453 and pharmacy systems are compatible with the CPOE system in the nursing home. New transaction fees may be incurred with CPOE, charged by intermediaries connecting the LTC facility to the pharmacy. Although these fees may represent the costs of ensuring that information is transmitted according to industry standards and to certify the entities that are in the network, the responsibility for paying these fees may have important implications. Should LTC facilities, physicians, or pharmacies be made responsible for these transaction fees, it will serve to exacerbate the economic imbalance between the stakeholders responsible for purchasing the health information technology and those potentially benefiting most from its adoption and use: payers (insurers) and residents of nursing homes. These additional costs may serve to diminish enthusiasm for widespread adoption and use of CPOE with CDS in LTC facilities, especially if the nursing home or physician becomes responsible for these additional costs. Physicians will also have acquisition costs related to the purchase of compatible hardware and software for their offices, because a substantial amount of clinical decisionmaking relating to the care of residents of LTC facilities occurs off site. A survey conducted by the American Medical Association indicated that, of physicians who practice in nursing homes, the majority spend 2 hours or less per week caring for their patients on site. 8 Annual costs for the facility will entail the cost of maintaining, supporting, and upgrading the CPOE and CDS systems, as well as updating the clinical and pharmaceutical information contained in the CDS system. Annual costs also include on-going training as new staff is introduced to the system and old staff is informed about system changes, including upgrades. Finally, under capitated arrangements, laboratory costs for the facility may increase under CDS as providers are prompted to conduct additional tests to monitor drug therapy. A reduction in costs related to adverse drug events may offset this increase in laboratory costs due to improvements in appropriate monitoring of patients. With the implementation of CPOE, there should be efficiency gains in the LTC facility in terms of medication ordering and elimination of prescribing errors. Nurses will play an integral role in the use of CPOE and, although initially the time required by nurses will be high, nursing time could decrease as efficiency and familiarity with the new system increases. In their assessment of CPOE systems in the inpatient setting, one study found that CPOE reduces time spent clarifying orders and increases the amount of time that nurses have available to spend on direct patient care. 9 In the LTC setting, nurses may be required to perform additional monitoring for adverse drug effects, as directed by the computerized alerts, and therefore the overall net efficiency gain for nurses is uncertain. The CPOE system is likely to lower future costs for laboratories and pharmacies as paper-based orders are eliminated, the process of ordering medications and tests is streamlined, and errors in transmission are reduced. The system may also reduce the time spent by pharmacists clarifying improper or incorrect prescriptions. In addition, the use of CPOE with CDS may lead to a reduction in the number of drugs, drug dosage prescribed, or the number of doses per day, with resulting reductions in costs. Cost savings from changes in type of medications prescribed (use of generics or lower-tier drugs when applicable) could also result in cost savings in LTC facilities, but the magnitude of these savings is unknown. In the hospital setting, CPOE with CDS has led to substantial reductions in pharmacy costs due to dose recommendations for selected high-cost medications. 10 In addition to steering prescribers toward more cost-effective choices, improved management of drug therapy has the potential to lead to fewer medical errors and associated adverse drug events. The ability to access electronic data in a comprehensive and efficient manner may enhance the ability to perform quality assurance type projects. More-ambitious projects may be possible. It may also allow a LTC facility to more readily participate in research projects. In addition, the widespread use of this technology in the LTC setting may lead to a dramatic change in the role and activities of the consultant pharmacists. The ability to access electronic data provides an opportunity for the consultant pharmacist to perform responsibilities that have depended on tedious and time-consuming retrospective review of paper records and an inefficient process for communicating with the prescriber. One can see the role of the consultant pharmacist evolving to leading the development and implementation of CDS systems that address quality concerns preemptively, rather than after the fact. CPOE and CDS in the LTC setting may increase the time spent by physicians in placing medication orders, even after the initial learning phase. Although no studies examining this in the LTC setting have been published, in the acute care setting, three studies have measured changes in physician time placing orders; these studies have consistently demonstrated substantial increases in physician time per working shift On average there was a 238% increase in physician ordering time. In these studies, there is no clear evidence that, after the initial learning period, physician time is neutral or unchanged from before CPOE implementation. One study reported an increase of 5.5 minutes per patient to write electronic orders in the inpatient setting. 11 These experiences in the acute care setting may not be entirely generalizable to the LTC setting, but such reports strongly suggest that physician time relating to placing orders will increase to some extent. Factors Affecting Cost and Benefits Whether CPOE with CDS is cost-effective or results in cost savings will depend on a number of factors related to the health information technology software, the overall organization of the healthcare system, and the specific LTC facility. The effect of these factors needs to be considered in any cost benefit analysis of CPOE or CDS. Ten distinct factors have been identified that could affect the magnitude of costs and benefits in the LTC setting. Factors Related to Health Information Technology Software Level of Functionality of the System The functionality of the system is a critical component that affects the magnitude of the costs and benefits and the potential return on investment. Health information technology systems can range from a simple view-only repository
4 1454 SUBRAMANIAN ET AL. SEPTEMBER 2007 VOL. 55, NO. 9 JAGS of clinical data to those that can provide guidance to the healthcare provider relating to medication management and test ordering. CPOE, for instance, represents a lower level of functionality than a CDS system. Cost increases with the level of functionality of the system, and the higher the level of functionality, the greater the potential benefit to be derived. Therefore, the cost benefit ratio may differ based on the level of functionality of the total system. Unintended Consequences Although advantages of CPOE include elimination of handwriting identification problems, reduction in error associated with similar drug names, more-efficient delivery of orders to the pharmacy, and integration with CDS systems that can provide prompts regarding serious drug interactions and for increased patient monitoring, implementation of CPOE with CDS may lead to the occurrence of new types of errors. The unintended consequences of computerization have been widely studied, and the findings indicate that introducing new technology into complex healthcare organizations can pose considerable challenges. In the acute care setting, one study reported 22 types of medication error risks ranging from fragmented CPOE displays that do not allow for a coherent view of a patient s medications to inflexible ordering formats that generate incorrect orders. 14 Use of systems that do not address such issues effectively could reduce quality of care and the level of patient safety. 15,16 Differences in Software Systems A CPOE system has the potential to provide access to comprehensive information for healthcare providers about the medications that a resident is taking, even when off site. Physicians who care for residents of LTC facilities often perform these activities in addition to their office practice and hospital rounding responsibilities or when on call during off-hours and weekends while covering other physicians. They may provide care for only a few individuals residing in a number of different LTC facilities, potentially resulting in the need to work with different CPOE and CDS systems. This could increase the challenges for the physician, resulting in an overall reduction in productivity and quality of patient care. Physicians may also become resistant to using these systems. 17 In one survey, almost 58% of hospitals with fully implemented CPOE found that substantial numbers of orders continued to be handwritten, bypassing the implemented CPOE system. 18 Physicians (and nurse practitioners) may respond similarly when providing care in LTC facilities. Furthermore, they may find the use of telephone orders to be less cumbersome than navigating different CPOE systems when ordering medications off site. Factors Related to the Healthcare System Level of Connectivity in the System A system involving multiple stakeholders provides the potential for greater benefit than one with only a limited number of connected entities when CPOE or CDS is implemented. Connectivity is the extent to which physicians, LTC facilities, pharmacies, and laboratories are linked electronically and communicate with each other. Costs and benefits will differ based on the level of connectivity and the number of relevant users of the system. Interoperability of Software Interoperability describes the way in which different software systems work together. The national Alliance for Health Information Technology defines interoperability as the ability of different information technology systems and software applications to communicate; to exchange data accurately, effectively, and consistently; and to use the information that has been exchanged. In the LTC setting, there are a large number of stakeholders whose systems need to connect and function together. The greater the interoperability of the software packages that are available, the higher the probability that the savings anticipated with the implementation of these systems will be realized. Late Versus Early Adopter Facilities that purchase and install these systems initially may have higher start-up and operating costs because of low connectivity, low interoperability, and implementation challenges that need to be overcome for the system to perform effectively. Facilities that delay their purchases may incur lower costs. Appropriate incentives should be available to encourage adoption of these systems and compensate early adopters for the higher start-up costs that they will have to incur. An attractive approach promoted by the ehealth Initiative Foundation is to have incentives for the adoption and use of health information technology tied directly to the goal of improving the quality of health care in terms of process and outcomes (e.g., improvements in the quality of medication prescribing and reduction in the frequency of preventable adverse drug events). 19 A potentially troubling strategy for providing incentives for the use of such systems involves the provision of a free electronic health records system in return for use of patient data (deidentified) that can be sold to pharmaceutical companies; another entrepreneurial strategy makes free systems available to physicians who allow advertisements to display in real time that are relevant to a specific patient s medical conditions. Such efforts have not yet extended into the LTC setting. LTC Facility Characteristics Level of Information Technology There are substantial set-up costs associated with purchasing and implementing the CPOE and CDS systems. Overall, savings will only be realized if cost reduction due to improvements in process efficiency and patient outcomes offset the upfront cost of implementing the system and longterm maintenance. It is estimated that CPOE at a single, 500-bed hospital would cost $7.90 million to implement and operate and an additional $1.35 million annually for ongoing costs. 20 This cost would increase if the organization did not already have high-capacity network capabilities needed for CPOE and an existing system that contains clinical information that can be integrated into the CPOE system. Therefore, the level of existing information technology in the LTC facility will be a critical determinant of the magnitude of the up-front acquisition costs that will be incurred.
5 JAGS SEPTEMBER 2007 VOL. 55, NO. 9 HEALTH INFORMATION TECHNOLOGY IN LONG-TERM CARE 1455 Size of the Organization Larger facilities will have a different cost benefit scenario than smaller facilities. Larger LTC facilities or chains may experience greater economies of scale in purchasing and implementing CPOE and CDS systems than smaller facilities. Costs associated with infrastructure, information technology staff, interfaces, and implementation can be shared across a larger base, and in addition, because large facilities have more residents, they may experience larger savings attributable to improvements in care, including prevention of adverse drug events. Larger facilities and chains may also have access to a higher level of expertise in selecting the CPOE and CDS systems. Greater efficiencies may be possible with large LTC facility chains and large pharmacies and laboratories working in concert. Nationwide, more than 50% of LTC facilities are part of chains. 21 Still, it would be hoped that smaller facilities might learn from the experience of larger facilities, facilitating the use of these systems across the full spectrum of nursing homes. Purchase Price The price of the software and hardware purchased by the LTC facility may be lower than the retail price because of volume discounts (specifically for nursing home chains), and the actual purchase price of these items will affect the cost benefit ratio. Type of Resident Pool The type of population at a particular nursing home will determine the extent of savings that can be achieved from the reduction in adverse drug events. Several studies have identified residents who are at greater risk of having an adverse drug event. 1 In settings where there is a higher proportion of these residents, it may be more likely that savings will be experienced. Not All Stakeholders Will Share Costs and Benefits Equally An overall estimation of costs and benefits in the LTC setting provides an assessment at the system level but does not provide information on the specific effects on the individual stakeholders. Analysis from each stakeholder s perspective (the nursing home, physician, nurse, pharmacy, laboratory, and payer) is essential to identifying potential misalignment of costs versus benefits. Table 2 indicates the likely direction of the increase or decrease in cost due to the implementation of CPOE with CDS for the selected stakeholders. The activities are grouped into five categories: implementing and Table 2. Costs Associated with Computerized Physician/Provider Order Entry (CPOE) with Clinical Decision Support (CDS) in the Long-Term Care (LTC) Setting Item LTC Facility Physician Nurse Pharmacy Laboratory Payer Implementing and maintaining CPOE/CDS Purchasing system "? Installing, testing, and calibrating system " Maintaining system " Upgrading system " Upgrading clinical information " Staff training " " " " " Time spent learning new system " " " " Ordering prescription Time spent placing orders directly " # Time spent responding to pop-up messages " Total number of prescriptions ordered # Time spent ordering and conducting laboratory tests " " " Number of laboratory tests " Filling prescription Time spent handling and reading orders # Time spent preparing and dispensing orders # Total number of prescriptions filled # Use of brand name medications (substituted w/generics) # Administering prescription Time spent verifying drug with order # Time spent identifying, locating, and preparing drug # Time spent administering drug # Time spent documenting administration of drug # Monitoring patients Time spent monitoring patients " Number of adverse drug events # Time to perform quality assurance and research # # # Payer effects shown are related to fee-for-service contract mechanism for all services.
6 1456 SUBRAMANIAN ET AL. SEPTEMBER 2007 VOL. 55, NO. 9 JAGS maintaining the system, ordering prescriptions, filling prescriptions, administering medication, and monitoring residents. All stakeholders will experience increased costs either due to direct purchases required to implement the system or as opportunity costs due to lost time. For activities related to ordering prescriptions, some stakeholders will benefit, and others will not. Filling prescriptions, administering medication, and monitoring residents are tasks that may benefit from increased efficiencies, but not all stakeholders may share these benefits. The benefits relating to reductions in the occurrence of preventable adverse drug events may accrue to multiple stakeholders. Even those without direct financial benefits may achieve indirect benefits, as in the case of physicians for whom malpractice liability might be reduced by virtue of fewer errors, improved patient safety, and a reduced risk of patient injury. Nevertheless, it should be emphasized that no published study has yet demonstrated a reduction in preventable adverse drug events with the use of CPOE with CDS in the LTC setting. Nursing homes and physicians are the stakeholders who may experience some negative effects. The nursing home will have substantial start-up costs if these costs are not shared with other stakeholders (e.g., the payer, laboratory, or pharmacy). Physicians (and nurse practitioners) are likely to devote more of their time ordering medications using CPOE with CDS and, if not compensated for these additional tasks, will bear the burden. Some important benefits, including a reduced need for clarification of orders from the pharmacy (fewer telephone calls and faxes to respond to) and fewer requests to address pharmacotherapeutic issues from the consultant pharmacist, may offset this increased effort by prescribers. There may be substantial misalignments of incentives based on how the providers (e.g., physicians, laboratories, and pharmacy) are reimbursed. For example, under capitated arrangements (in which payers pay a fixed amount for each year of care and the provider assumes the risk), the providers will retain any savings. Under a fee-for-service arrangement (in which payment is based on submitted charges), savings will accrue primarily to the payer. Therefore, the level of capitation will be critical in determining the magnitude of costs and benefits to the stakeholders involved. CPOE with CDS in LTC Facilities: Relationship to the Medicare Prescription Drug, Improvement, and Modernization Act A number of challenges relevant to the Medicare Prescription Drug, Improvement, and Modernization Act in the LTC setting may be more efficiently addressed with the availability of CPOE with CDS. As many different drug plans may serve residents of a single LTC facility, with different formularies, step therapy mandates, and prior authorization policies, CPOE with CDS may provide an opportunity to prompt the prescriber to make prescribing decisions consistent with these varying policies. In addition, some medications that residents of LTC facilities commonly use are not covered under Medicare Part D, and the CDS system may have the capacity to make the prescriber aware of this limitation in coverage before filing an order for the drug. These systems may also have the ability to respond to the changes in coverage or drug plans that occur with transitions to Medicaid eligibility. SUMMARY This consideration of the costs and benefits related to implementation of CPOE with CDS in the LTC setting indicates that multiple stakeholders will incur the costs of implementing and maintaining these systems but that the costs that each incurs may not be fully aligned with the benefits. Recognition of the costs and benefits borne by the various participants and the substantial time lag in the realization of benefits suggests that incentives may be necessary to enhance adoption of these systems. For instance, under a fee-for-service mechanism, payers could offset costs to the nursing home for implementing the system through direct subsidies or other forms of incentive payments. Successful adoption of health information technology depends on physician, nurse practitioner, and nurse receptivity to using these systems. Incentives, nonmonetary or monetary, may need to be in place to encourage and ensure widespread use. Insurers, such as Blue Cross and Blue Shield, are starting to make bonus payments to physicians for implementation of health information technology and electronic communications; such initiatives can play an important role in adoption and use of health information technology in the LTC setting. If physicians are required to navigate across multiple different systems to care for their patients, their willingness to participate will be lower. Local and regional health initiatives, such as the Massachusetts ehealth Collaborative, the Indiana Heath Information Exchange, and the California Regional Health Information Organization, may help foster coordination and collaboration between diverse healthcare stakeholders and lead to the adoption of standardized systems. This review provides a framework for considering the potential benefits and costs for stakeholders involved in health information technology integration and operations, with a particular focus on CPOE with CDS in the LTC setting. An accurate determination of the magnitude of the costs and savings will be essential to completely understand effects on individual stakeholders. Future studies of these technologies in the LTC setting must incorportate these measures to provide the information necessary to guide and facilitate widespread implementation and use of these systems. ACKNOWLEDGMENTS Financial Disclosure: Sujha Subramanian, Sonja Hoover, Boyd Gilman, Terry S. Field, and Jerry H. Gurwitz received research support from the Agency for Healthcare Research and Quality (HS and HS15430). Ryan Mutter is employed by the Agency for Healthcare Research and Quality. Author Contributions: All authors contributed to the concept and design, acquisition and analysis of data, and preparation of the manuscript. Sponsor s Role: The sponsor had no role in the design concept, acquisition of data, analysis of data, manuscript preparation, or the decision to submit the manuscript for publication.
7 JAGS SEPTEMBER 2007 VOL. 55, NO. 9 HEALTH INFORMATION TECHNOLOGY IN LONG-TERM CARE 1457 REFERENCES 1. Gurwitz JH, Field TS, Judge J et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005;118: Bates DW, Leape LL, Cullen DJ et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280: Poon EG, Jha AK, Christino M et al. Assessing the level of healthcare information technology adoption in the United States: A snapshot. BMC Med Inform Decis Mak 2006;6: Rochon PA, Field TS, Bates DWet al. Computerized physician order entry with clinical decision support in the long-term care setting: Insights from the Baycrest Centre for Geriatric Care. J Am Ger Soc 2005;53: Poissant L, Pereira J, Tamblyn R et al. The impact of electronic health records on time efficiency of physicians and nurses: A systematic review. J Am Med Inform Assoc 2005;12: Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: A systematic review. Arch Intern Med 2003;163: National Spending for Long-Term Care. LTC Financing Project Georgetown University [on-line]. Available at spending2007.pdf Accessed January 24, Levy C, Epstein A, Landry L et al. Literature review and synthesis of physician practices in nursing homes [on-line]. October 17, Available at Accessed July 17, Andrews T, DiFrancesco M, Gilliam M et al. Putting CPOE to work. Nurs Manage 2003;(Suppl): Teich JM, Schmiz JL, O Connell EM et al. An information system to improve the safety and efficiency of chemotherapy ordering. Proc AMIA Symp 1996, pp Tierney WM, Miller ME, Overhage JM et al. Physician inpatient order writing on microcomputer workstations. Effects on resource utilization. JAMA 1993;269: Bates DW, Kuperman G, Teich JM. Computerized physician order entry and quality of care. Qual Manag Health Care 1994;2: Shu K, Boyle D, Spurr C et al. Comparison of time spent writing orders on paper with computerized physician order entry. Medinfo 2001;10(Part 2): Koppel R, Metlay JP, Cohen A et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA 2005;293: Han YY, Carcillo JA, Venkataraman ST et al. Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system. Pediatrics 2005;116: Nebeker JR, Hoffman JM, Weir CR et al. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005;165: Shojania KG, Wald H, Gross R. Understanding medical error and improving patient safety in the inpatient setting. Med Clin North Am 2002;86: Ash JS, Gorman PN, Hersh WR. Physician order entry in US hospitals. Proc AMIA Symp 1998, pp debrantes F, Glaser J, Marchibroda J.Financial Incentives for Adoption of Health Information Technology by Healthcare Deliverers [on-line]. Available at Accessed May 17, Computerized Physician Order Entry: Costs, Benefits and Challenges of CPOEFA Case Study Approach First Consulting Group [on-line]. Available at cpoerep030attach.pdf#search= CPOE%20FCG Accessed January 22, CMS-OSCAR Form 671 Current Survey as of June Centers for Medicare and Medicaid Services [on-line]. Available at car_oper.htm Accessed January 25, 2007.
Concept Series Paper on Electronic Prescribing
Concept Series Paper on Electronic Prescribing E-prescribing is the use of health care technology to improve prescription accuracy, increase patient safety, and reduce costs as well as enable secure, real-time,
e -Prescribing An Information Brief
e -Prescribing An Information Brief Prepared by: Maryland Health Care Commission June 2008 Introduction Technology creates efficiencies and opportunities in almost every industry, and health care is no
c. determine the factors that will facilitate/limit physician utilization of pharmacists for medication management services.
Consumer, Physician, and Payer Perspectives on Primary Care Medication Management Services with a Shared Resource Pharmacists Network Marie Smith, PharmD and Michlle Breland, PhD University of Connecticut,
OPTIMIZING THE USE OF YOUR ELECTRONIC HEALTH RECORD. A collaborative training offered by Highmark and the Pittsburgh Regional Health Initiative
OPTIMIZING THE USE OF YOUR ELECTRONIC HEALTH RECORD A collaborative training offered by Highmark and the Pittsburgh Regional Health Initiative Introductions Disclosures Successful completion of training
Medication error is the most common
Medication Reconciliation Transfer of medication information across settings keeping it free from error. By Jane H. Barnsteiner, PhD, RN, FAAN Medication error is the most common type of error affecting
PROPOSED US MEDICARE RULING FOR USE OF DRUG CLAIMS INFORMATION FOR OUTCOMES RESEARCH, PROGRAM ANALYSIS & REPORTING AND PUBLIC FUNCTIONS
PROPOSED US MEDICARE RULING FOR USE OF DRUG CLAIMS INFORMATION FOR OUTCOMES RESEARCH, PROGRAM ANALYSIS & REPORTING AND PUBLIC FUNCTIONS The information listed below is Sections B of the proposed ruling
Prescription drugs are a critical component of health care. Because of the role of drugs in treating conditions, it is important that Medicare ensures that its beneficiaries have access to appropriate
EMR Benefits and Benefit Realization Methods of Stage 6 and 7 Hospitals Hospitals with advanced EMRs report numerous benefits.
EMR Benefits and Benefit Realization Methods of Stage 6 and 7 Hospitals Hospitals with advanced EMRs report numerous benefits February, 2012 2 Table of Contents 3 Introduction... 4 An Important Question...
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE April 8, 2011 EFFECTIVE DATE April 8, 2011 MEDICAL ASSISTANCE BULLETIN NUMBER 03-11-01, 09-11-02, 14-11-01, 18-11-01 24-11-03, 27-11-02, 31-11-02, 33-11-02 SUBJECT Electronic Prescribing Internet-based
CompPharma. Manage. Process. Inform. Ensure. The Role of a PBM in Workers Compensation
Manage Inform Process Ensure The Role of a PBM in Workers Compensation Understanding the role of workers compensation pharmacy benefit managers (WC-PBMs) can help state and local government agencies ensure
Issue Brief Findings from HSC
Issue Brief Findings from HSC NO. 133 JULY 2010 EVEN WHEN PHYSICIANS ADOPT E-PRESCRIBING, USE OF ADVANCED FEATURES LAGS By Joy M. Grossman Physician practice adoption of electronic prescribing has not
BIBLIOGRAPHICAL REVIEW ON COST OF PATIENT SAFETY FAILINGS IN ADMINISTRATION OF DRUGS. SUMMARY.
BIBLIOGRAPHICAL REVIEW ON COST OF PATIENT SAFETY FAILINGS IN ADMINISTRATION OF DRUGS. SUMMARY. Bibliographical review on cost of Patient Safety Failings in administration of drugs. Summary This has been
INSTRUCTIONS Return on Investment Estimation
INSTRUCTIONS Return on Investment Estimation What is this tool? When your hospital invests in a new program, quality improvement intervention, or technology, management often wants to know what kind of
Comments to Legislative Workgroup on E-Prescribing
Comments to Legislative Workgroup on E-Prescribing eqhealth Solutions is a not-for-profit, physician sponsored health care organization operating in Louisiana, Illinois, Florida and Mississippi. It has
Introduction. Plan sponsors include employers, unions, trust funds, associations and government agencies, and are also referred to as payors.
Maintaining the Affordability of the Prescription Drug Benefit: How Managed Care Organizations Secure Price Concessions from Pharmaceutical Manufacturers Introduction The purpose of this paper is to explain
GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION
GUIDELINES GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION Preamble The purpose of this document is to provide guidance for the pharmacist
Conflict of Interest Disclosure
Leveraging Clinical Decision Support for Optimal Medication Management Anne M Bobb, BS Pharm., Director Quality Informatics Children s Memorial Hospital, Chicago IL, February 20, 2012 DISCLAIMER: The views
Medweb Telemedicine 667 Folsom Street, San Francisco, CA 94107 Phone: 415.541.9980 Fax: 415.541.9984 www.medweb.com
Medweb Telemedicine 667 Folsom Street, San Francisco, CA 94107 Phone: 415.541.9980 Fax: 415.541.9984 www.medweb.com Meaningful Use On July 16 2009, the ONC Policy Committee unanimously approved a revised
Advancements in Technology to Streamline and Expedite Patient Access. CBI Reimbursement & Access AUG 13, 2015 @ 2:15PM
Advancements in Technology to Streamline and Expedite Patient Access CBI Reimbursement & Access AUG 13, 2015 @ 2:15PM Learning Objectives Assess the current and future landscape as it relates to erx Understand
Inpatient EHR. Solution Snapshot. The right choice for your patients, your practitioners, and your bottom line SOLUTIONS DESIGNED TO FIT
Inpatient EHR The right choice for your patients, your practitioners, and your bottom line SOLUTIONS DESIGNED TO FIT Our customers do more than save lives. They re helping their communities to thrive.
T h e M A RY L A ND HEALTH CARE COMMISSION
T h e MARYLAND HEALTH CARE COMMISSION Discussion Topics Overview Learning Objectives Electronic Health Records Health Information Exchange Telehealth 2 Overview - Maryland Health Care Commission Advancing
WHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain
WHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing
3/9/2011 ELECTRONIC HEALTH RECORDS: A NATIONAL PRIORITY. Mandate for electronic health records is tied to:
To lower health care cost, cut medical errors, And improve care, we ll computerize the nation s health records in five years, saving billions of dollars in health care costs and countless lives. ELECTRONIC
Field Report Field Report Field Report Field Report Field Report
Starting a Pharmaceutical Program Program for Pharmaceutical Care A report written by organizers of volunteerbased health care programs serving the uninsured. 1 to Underserved PHARMACEUTICAL Starting a
Custom Report Data Elements: IT Database Fields. Source: American Hospital Association IT Survey
Custom Report Data Elements: IT Database Fields Source: American Hospital Association IT Survey TABLE OF CONTENTS COMPUTERIZED SYSTEM IMPLEMENTATION... 4 Bar Coding... 4 Computerized Provider Order Entry...
The Massachusetts Coalition for the Prevention of Medical Errors. MHA Best Practice Recommendations to Reduce Medication Errors
The Massachusetts Coalition for the Prevention of Medical Errors MHA Best Practice Recommendations to Reduce Medication Errors Executive Summary In 1997, the Massachusetts Coalition for the Prevention
eprescribing Information to Improve Medication Adherence
eprescribing Information to Improve Medication Adherence January 2014 This white paper was funded by the Pharmaceutical Research and Manufacturers of America. About Point-of-Care Partners Point-of-Care
ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT
ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT Accountable Care Analytics: Developing a Trusted 360 Degree View of the Patient Introduction Recent federal regulations have
Maryland Medicaid Program
Maryland Medicaid Program Maryland s Pharmacy Discount Waiver Tuesday, November 19, 2002 Debbie I. Chang Deputy Secretary for Health Care Financing Maryland Department of Health and Mental Hygiene Overview
Health Record Banking Alliance
Health Record Banking Alliance From: William A. Yasnoff, MD, PhD, President, Health Record Banking Alliance To: Regulations.Gov Website at http://www.regulations.gov/search/regs/home.html#home Date: May
1. Introduction - Nevada E-Health Survey
1. Introduction - Nevada E-Health Survey Welcome to the Nevada E-Health Survey for health care professional providers and hospitals. The Office of Health Information Technology (OHIT) for the State of
US Hospital Information Systems Overview and Outlook, 2013 2020 Managing Information in an Era of Reform
US Hospital Information Systems Overview and Outlook, 2013 2020 Managing Information in an Era of Reform December 2014 Contents Section Slide Number Executive Summary 11 Market Background 19 The EHR Landscape
TESTIMONY. The Potential Benefits and Costs of Increased Adoption of Health Information Technology RICHARD HILLESTAD CT-312.
TESTIMONY The Potential Benefits and Costs of Increased Adoption of Health Information Technology RICHARD HILLESTAD CT-312 July 2008 Testimony presented before the Senate Finance Committee on July 17,
Meaningful Use. Medicare and Medicaid EHR Incentive Programs
Meaningful Use Medicare and Medicaid Table of Contents What is Meaningful Use?... 1 Table 1: Patient Benefits... 2 What is an EP?... 4 How are Registration and Attestation Being Handled?... 5 What are
Examining the Medicare Part D Medication Therapy Management (MTM) Program: Improving Medicare MTM for the Future
Examining the Medicare Part D Medication Therapy Management (MTM) Program: Improving Medicare MTM for the Future Statement of S. Lawrence Kocot Principal and National Leader Center for Healthcare Regulatory
PROGRESS IN ELECTRONIC HEALTH RECORD IMPLEMENTATION THROUGH HRSA GRANTS TO HEALTH CENTER CONTROLLED NETWORKS
Department of Health and Human Services OFFICE OF INSPECTOR GENERAL PROGRESS IN ELECTRONIC HEALTH RECORD IMPLEMENTATION THROUGH HRSA GRANTS TO HEALTH CENTER CONTROLLED NETWORKS Daniel R. Levinson Inspector
HEALTHCARE REFORM SOLUTIONS. Designing a Pharmacy Benefit for the New Public Health Exchange Consumers
HEALTHCARE REFORM SOLUTIONS Designing a Pharmacy Benefit for the New Public Health Exchange Consumers FEBRUARY 2013 EXECUTIVE SUMMARY Designing a Pharmacy Benefit for the New Public Health Insurance Exchange
Are Electronic Medical Records Worth the Costs of Implementation?
Research Are Electronic Medical Records Worth the Costs of Implementation? TARA O'NEILL AUGUST 6, 2015 Executive Summary Electronic medical records (EMRs), as a cornerstone of a more intelligent, adaptive,
Dr. Peters has declared no conflicts of interest related to the content of his presentation.
Dr. Peters has declared no conflicts of interest related to the content of his presentation. Steve G. Peters MD NAMDRC 2013 No financial conflicts No off-label usages If specific vendors are named, will
Health Information Technology
Health Information Technology chartbook volume II Maine Hospitals Survey 2010 UNIVERSITY OF SOUTHERN MAINE Health Information Technology Maine Hospitals Survey Volume II Authors Martha Elbaum Williamson,
PHARMACY BENEFIT DESIGN CONSIDERATIONS
PHARMACY BENEFIT DESIGN CONSIDERATIONS Is your pharmacy benefit designed for your employees or the big drug companies? The pharmacy (or prescription) benefit is one of the most sought after benefits by
Strengthening Community Health Centers. Provides funds to build new and expand existing community health centers. Effective Fiscal Year 2011.
Implementation Timeline Reflecting the Affordable Care Act 2010 Access to Insurance for Uninsured Americans with a Pre-Existing Condition. Provides uninsured Americans with pre-existing conditions access
(RIN) 0906-AB08; 340-B
October, 2015 Ms. Krista Pedley Director, Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane, Mail Stop 08W05A Rockville, Maryland 20857 Re: Regulatory
Evidenced Based Nursing: Electronic Medical Charting and Patient Safety
Evidenced Based Nursing: Electronic Medical Charting and Patient Safety Presented By Nicole Chambers, Sharon Herring, Sheila Lucas, and Shelley Meyerholtz Introduction In the 1999 publication of To Err
The Healthcare Provider Industry Short List: Inpatient Electronic Medical Records Judy Hanover Research Manager, Healthcare Provider IT Strategies
The Healthcare Provider Industry Short List: Inpatient Electronic Medical Records Judy Hanover Research Manager, Healthcare Provider IT Strategies Webcast Logistics Audio lines are muted until Q&A session
Health Information Technology in the United States: Information Base for Progress. Executive Summary
Health Information Technology in the United States: Information Base for Progress 2006 The Executive Summary About the Robert Wood Johnson Foundation The Robert Wood Johnson Foundation focuses on the pressing
Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach
Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach When it comes to supporting the clinical and marketing objectives of any pharmaceutical franchise, helping to remove
QBE A&H, LLC RISK MANAGEMENT GUIDE
QBE A&H, LLC RISK MANAGEMENT GUIDE PHILOSOPHY 1 CONFIDENTIALITY 1 UNDERWRITING PROCESS 1 RISK MANAGEMENT PROCESS 1 SPECIALTY RISK MANGMENT VENDORS 3 OUTCOME-BASED CENTERS OF EXCELLENCE 3 DIALYSIS COST
STAGE 2 of the EHR Incentive Programs
EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) Eligible Professional s Guide to STAGE 2 of the EHR Incentive Programs September 2013 TABLE OF CONTENTS...
Clinical Decision Support
Goals and Objectives Clinical Decision Support What Is It? Where Is It? Where Is It Going? Name the different types of clinical decision support Recall the Five Rights of clinical decision support Identify
The Challenge of Implementing Interoperable Electronic Medical Records
Annals of Health Law Volume 19 Issue 1 Special Edition 2010 Article 37 2010 The Challenge of Implementing Interoperable Electronic Medical Records James C. Dechene Follow this and additional works at:
Views from the Nation: An Overview of
Views from the Nation: An Overview of E Prescribing Experiences From thestates Co sponsored by the NCSL/FSL Transforming Health Through Technology Project and HIMSS Moderator: Representative Peggy Welch,
Efficiency Gains with Computerized Provider Order Entry
Efficiency Gains with Computerized Provider Order Entry Andrew M. Steele, MD, MPH, MSc; Mical DeBrow, PhD, RN Abstract Objective: The objective of this project was to measure efficiency gains in turnaround
Formulary Management
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
North Carolina Medicaid Special Bulletin
North Carolina Medicaid Special Bulletin An Information Service of the Division of Medical Assistance Please visit our Web site at www.ncdhhs.gov/dma July 2007 ATTENTION: All Providers Notice of Change
Achieving meaningful use of healthcare information technology
IBM Software Information Management Achieving meaningful use of healthcare information technology A patient registry is key to adoption of EHR 2 Achieving meaningful use of healthcare information technology
Adopting Electronic Medical Records: What Do the New Federal Incentives Mean to Your Individual Physician Practice?
Adopting Electronic Medical Records: What Do the New Federal Incentives Mean to Your Individual Physician Practice? U John M. Neclerio, Esq.,* Kathleen Cheney, Esq., C. Mitchell Goldman, Esq., and Lisa
The State of EHR Adoption: On the Road to Improving Patient Safety
The State of EHR Adoption: On the Road to Improving Patient Safety SPONSORED BY VMWare The State of ehr adoption Whether the designation is electronic medical records (EMR) or electronic health records
Achieving Meaningful Use in Private Practice. A close examination of Stage 2 requirements
Achieving Meaningful Use in Private Practice A close examination of Stage 2 requirements Abstract As part of the American Recovery and Reinvestment Act of 2009, the Federal Government laid the groundwork
Medical Care Advisory Committee. Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission
TO: Medical Care Advisory Committee DATE: November 8, 2013 FROM: Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission Agenda Item No.: 7 SUBJECT: Fee-for-Service
Rebates and Discounts on Physician-Administered Drugs. Medicaid Program Department of Health
New York State Office of the State Comptroller Thomas P. DiNapoli Division of State Government Accountability Rebates and Discounts on Physician-Administered Drugs Medicaid Program Department of Health
The Meaningful Use Stage 2 Final Rule: Overview and Outlook
The Meaningful Use Stage 2 Final Rule: Overview and Outlook Devi Mehta, JD, MPH Cand. 1 Taylor Burke, JD, LLM 2 Lara Cartwright-Smith, JD, MPH 3 Jane Hyatt Thorpe, JD 4 Introduction On August 23, 2012,
Analysis of the Costs and Impact of Universal Health Care Coverage Under a Single Payer Model for the State of Vermont
Analysis of the Costs and Impact of Universal Health Care Coverage Under a Single Payer Model for the State of Vermont Prepared for: The Vermont HRSA State Planning Grant, Office of Vermont Health Access
PHASE II CORE 260 ELIGIBILITY & BENEFITS (270/271) DATA CONTENT RULE VERSION 2.1.0 SECTION 6.2 APPENDIX 2: GLOSSARY OF DATA CONTENT TERMS MARCH 2011
PHASE II CORE 260 ELIGIBILITY & BENEFITS (270/271) DATA CONTENT RULE VERSION 2.1.0 SECTION 6.2 APPENDIX 2: GLOSSARY OF DATA CONTENT TERMS MARCH 2011 CAQH 2008-2011. All rights reserved. 1 Table of Contents
LICENSING COMMITTEE AD-HOC Committee on Pharmaceutical Benefit Managers (PBMs) Regulation. Meeting Summary
California State Board of Pharmacy STATE AND CONSUMER SERVICES AGENCY 400 R Street, Suite 4070, Sacramento, CA 95814-6237 DEPARTMENT OF CONSUMER AFFAIRS Phone (916) 445-5014 GRAY DAVIS, GOVERNOR Fax (916)
